» Articles » PMID: 39026810

Dynamic Stress- and Inflammatory-based Regulation of Psychiatric Risk Loci in Human Neurons

Abstract

The prenatal environment can alter neurodevelopmental and clinical trajectories, markedly increasing risk for psychiatric disorders in childhood and adolescence. To understand if and how fetal exposures to stress and inflammation exacerbate manifestation of genetic risk for complex brain disorders, we report a large-scale context-dependent massively parallel reporter assay (MPRA) in human neurons designed to catalogue genotype x environment (GxE) interactions. Across 240 genome-wide association study (GWAS) loci linked to ten brain traits/disorders, the impact of hydrocortisone, interleukin 6, and interferon alpha on transcriptional activity is empirically evaluated in human induced pluripotent stem cell (hiPSC)-derived glutamatergic neurons. Of ~3,500 candidate regulatory risk elements (CREs), 11% of variants are active at baseline, whereas cue-specific CRE regulatory activity range from a high of 23% (hydrocortisone) to a low of 6% (IL-6). Cue-specific regulatory activity is driven, at least in part, by differences in transcription factor binding activity, the gene targets of which show unique enrichments for brain disorders as well as co-morbid metabolic and immune syndromes. The dynamic nature of genetic regulation informs the influence of environmental factors, reveals a mechanism underlying pleiotropy and variable penetrance, and identifies specific risk variants that confer greater disorder susceptibility after exposure to stress or inflammation. Understanding neurodevelopmental GxE interactions will inform mental health trajectories and uncover novel targets for therapeutic intervention.

References
1.
Borovcanin M, Jovanovic I, Radosavljevic G, Pantic J, Minic Janicijevic S, Arsenijevic N . Interleukin-6 in Schizophrenia-Is There a Therapeutic Relevance?. Front Psychiatry. 2017; 8:221. PMC: 5681495. DOI: 10.3389/fpsyt.2017.00221. View

2.
Ashuach T, Fischer D, Kreimer A, Ahituv N, Theis F, Yosef N . MPRAnalyze: statistical framework for massively parallel reporter assays. Genome Biol. 2019; 20(1):183. PMC: 6717970. DOI: 10.1186/s13059-019-1787-z. View

3.
Musa A, Tripathi S, Kandhavelu M, Dehmer M, Emmert-Streib F . Harnessing the biological complexity of Big Data from LINCS gene expression signatures. PLoS One. 2018; 13(8):e0201937. PMC: 6114505. DOI: 10.1371/journal.pone.0201937. View

4.
Lin L, Sibille E . Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?. Front Pharmacol. 2013; 4:110. PMC: 3766825. DOI: 10.3389/fphar.2013.00110. View

5.
Benson C, Powell H, Liput M, Dinham S, Freedman D, Ignatowski T . Immune Factor, TNFα, Disrupts Human Brain Organoid Development Similar to Schizophrenia-Schizophrenia Increases Developmental Vulnerability to TNFα. Front Cell Neurosci. 2020; 14:233. PMC: 7484483. DOI: 10.3389/fncel.2020.00233. View